Femasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education Program

Stock Information for Femasys Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Femasys Inc.

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
Femasys Announces Infertility Clinic Customers from Coast to Coast

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.